(Press-News.org) Patients with mild to moderate Alzheimer's disease (AD) who received supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA), believed to possibly reduce the risk of AD, did not experience a reduction in the rate of cognitive and functional decline, compared to patients who received placebo, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Joseph F. Quinn, M.D., of Oregon Health and Science University and the Portland VA Medical Center, Portland, Ore., presented the findings of the study at a JAMA media briefing at the National Press Club.
"Several studies have found that consumption of fish, the primary dietary source of omega-3 fatty acids, is associated with a reduced risk of cognitive decline or dementia. Some studies have found that consumption of DHA, but not other omega-3 fatty acids, is associated with a reduced risk of Alzheimer disease," the authors write. However, those studies were observational and did not control who received DHA. Animal studies that used DHA showed reductions in Alzheimer-like brain pathology.
Dr. Quinn and colleagues conducted a randomized, controlled trial to examine whether DHA supplementation would slow the rate of cognitive and functional decline in individuals with Alzheimer's disease. The study, which was conducted between November 2007 and May 2009 at 51 U.S. clinical research sites, included 402 individuals with mild to moderate Alzheimer's disease. Participants were randomly assigned to DHA at a dose of 2 grams/day or to identical placebo (60 percent were assigned to DHA and 40 percent were assigned to placebo). Duration of treatment was 18 months. Changes in cognitive and functional abilities were assessed with the Alzheimer's Disease Assessment Scale
(ADAS-cog) and the Clinical Dementia Rating (CDR) sum of boxes. Rate of brain atrophy was also determined by volumetric magnetic resonance imaging (MRI) in a subsample of participants.
A total of 295 participants completed the trial while taking study medication (DHA: 171; placebo: 124). The researchers found that supplementation with DHA had no beneficial effect on rate of change on ADAS-cog score, with the rate of average change in the score over 18 months being 8.27 points for the placebo group and 7.98 points for the DHA group. The rate of points change on CDR sum of boxes over 18 months was 2.93 for the placebo group compared with 2.87 for the DHA group.
Among the individuals participating in the MRI substudy (102 had MRIs at the beginning of the study and at 18 months [DHA group: 53; placebo group: 49]), an analysis showed no effect of DHA treatment on total brain volume change during 18 months.
"In summary, these results indicate that DHA supplementation is not useful for the population of individuals with mild to moderate Alzheimer disease," the authors write.
The researchers add that "because part of the rationale for the trial was epidemiological evidence that DHA use before disease onset modifies the risk of Alzheimer disease, it remains possible that an intervention with DHA might be more effective if initiated earlier in the course of the disease in patients who do not have overt dementia."
(JAMA. 2010;304[17]:1903-1911. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Please Note: For this study, there will be multimedia content available, including the JAMA Report video, embedded and downloadable video, audio files, text, documents, and related links. This content will be available at 10 a.m. ET Tuesday, November 2 at www.digitalnewsrelease.com/?q=jama_3763.
Editorial: Treatment of Alzheimer Disease and Prognosis of Dementia
In an accompanying editorial, Kristine Yaffe, M.D., of the University of California, San Francisco and Veterans Affairs Medical Center, San Francisco, comments on the findings of this study.
"This trial adds to a growing literature that treatment with DHA does not improve symptoms of AD. Although several observational studies reported that diets rich in fish or supplements with omega-3 fatty acids were associated with reduced risk of developing AD, most randomized clinical trials for treatment of AD or mild cognitive impairment or in healthy elderly individuals have not found a beneficial effect."
INFORMATION:
(JAMA. 2010;304[17]:1952-1953. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
To contact Joseph F. Quinn, M.D., call Ken Olsen at 503-494-8231 or email olsenke@ohsu.edu. To contact editorial author Kristine Yaffe, M.D., call Steve Tokar at 415-221-4810, ext. 5202 or email steve.tokar@ncire.org.
For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.
DHA 'fish oil' supplements do not seem to slow cognitive, functional decline in Alzheimer's disease
2010-11-03
ELSE PRESS RELEASES FROM THIS DATE:
Fly study uncovers molecular link between obesity and heart disease
2010-11-03
VIDEO:
Researchers show that obesity-induced heart disease can be prevented by reducing the activity of TOR, a nutrient-sensing protein that regulates molecular circuits involved in growth, metabolism and lifespan.
Click here for more information.
LA JOLLA, Calif., November 2, 2010 – It's no secret that obesity is hard on the heart. More than 30 percent of Americans are obese, and many of them are also at increased risk for cancer, diabetes and heart disease. However, there ...
Colorectal cancer survival advantage in MUTYH-associated polyposis
2010-11-03
Survival for colorectal cancer patients with MUTYH-associated polyposis was statistically significantly better than for patients with colorectal cancer from the general population, according to a recent study published online November 2 in The Journal of the National Cancer Institute.
People who inherit a mutation in the MUTYH gene have nearly a 100% risk for developing colon cancer at some point in their lifetimes. But it is unknown whether specific histological and molecular genetic features of cancer associated with this genotype influence tumor behavior and survival. ...
NIH researchers identify genetic elements influencing the risk of type 2 diabetes
2010-11-03
A team led by researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, has captured the most comprehensive snapshot to date of DNA regions that regulate genes in human pancreatic islet cells, a subset of which produces insulin.
The study highlights the importance of genome regulatory sequences in human health and disease, particularly type 2 diabetes, which affects more than 20 million people in the United States and 200 million people worldwide. The findings appear Nov. 3 in Cell Metabolism.
"This study applies ...
Bees reveal nature-nuture secrets
2010-11-03
The nature-nurture debate is a "giant step" closer to being resolved after scientists studying bees documented how environmental inputs can modify our genetic hardware. The researchers uncovered extensive molecular differences in the brains of worker bees and queen bees which develop along very different paths when put on different diets The research was led by Professor Ryszard Maleszka of The Australian National University's College of Medicine, Biology and Environment, working with colleagues from the German Cancer Institute in Heidelberg, Germany and will be published ...
How some brain cells hook up surprises researchers
2010-11-03
Immune cells known as microglia, long thought to be activated in the brain only when fighting infection or injury, are constantly active and likely play a central role in one of the most basic, central phenomena in the brain – the creation and elimination of synapses. The findings, publishing next week in the online, open access journal PLoS Biology, catapult the humble microglia cell from its well-recognized duty of protecting the brain to direct involvement in creating the cellular networks at the core of brain behavior. Its apparent role as an architect of synapses – ...
Fossil finger records key to ancestors' behavior
2010-11-03
Scientists, in collaboration with researchers at the universities of Southampton and Calgary, used finger ratios from fossilised skeletal remains of early apes and extinct hominins, as indicators of the levels of exposure species had to prenatal androgens – a group of hormones that is important in the development of masculine characteristics such as aggression and promiscuity.
It is thought that androgens, such as testosterone, affect finger length during development in the womb. High levels of the hormones increase the length of the fourth finger in comparison to the ...
Parental infertility and cerebral palsy in children born spontaneously or after IVF/ICSI
2010-11-03
Doctors have known for some time that children born after fertility treatments such as in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) are at increased risk of cerebral palsy. However, it was not known whether this risk was due to the treatment itself, the higher frequency of preterm or multiple births, or a mechanism associated with couples' underlying infertility.
Now, new research published online in Europe's leading reproductive medicine journal Human Reproduction [1] today (Wednesday 3 November) indicates that underlying infertility is not ...
Global map of the sickle cell gene supports 'malaria hypothesis'
2010-11-03
At a global scale, the sickle cell gene is most commonly found in areas with historically high levels of malaria, adding geographical support to the hypothesis that the gene, whilst potentially deadly, avoids disappearing through natural selection by providing protection against malaria.
In a study funded by the Wellcome Trust, geographers, biologists and statisticians at the University of Oxford, together with colleagues from the KEMRI-Wellcome Trust Programme in Kenya, have produced the first detailed global map showing the distribution of the sickle cell gene. The ...
Aging with grace: Health care delivery model yields improved outcomes and lower costs
2010-11-03
INDIANAPOLIS – A model program developed at Indiana University to provide care to low-income older adults in their homes has earned recognition for its effective approach and cost-saving benefits in a leading national medical journal.
A paper published in the Nov. 3 issue of the Journal of the American Medical Association praises a team approach developed by researchers from Indiana University and the Regenstrief Institute as one of three models with the greatest potential to improve the effectiveness and efficiency of the complex primary health care of older adults.
"Health-care ...
Black raspberries may prevent colon cancer, study finds
2010-11-03
Black raspberries are highly effective in preventing colorectal tumors in two mouse models of the disease, according to a University of Illinois at Chicago study.
The findings are published in the November issue of Cancer Prevention Research.
Colorectal cancer is the third most common cancer and the second leading cause of cancer-related death in both men and women in the U.S., according to the National Cancer Institute.
Building on previous research that found black raspberries have antioxidant, anti-cancer, anti-neurodegenerative and anti-inflammatory properties, ...